UAB "Imunodiagnostika" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 828,640 |
| 31,364 |
| 6,122 |
| 6,122 |
| 232 |
| 66.33 |
| 0.74 |
| 415,098 |
| 2,227,953 |
| 1,907,657 |
| 732,947 |
| 0.83 |
| 5.37 |
| - |
| - |
| 9.06 |
| 75,060 |
| 2023 |
|---|
| 521,378 |
| 32,124 |
| 32,433 |
| 31,899 |
| 1,965 |
| 62.66 |
| 6.12 |
| 446,997 |
| 1,985,372 |
| 1,977,071 |
| 451,991 |
| 0.66 |
| 4.44 |
| - |
| - |
| 19.24 |
| 100,293 |
| 2024 |
|---|
| 871,720 |
| 62,940 |
| -421,468 |
| -421,468 |
| -30,431 |
| 33.98 |
| -48.35 |
| 25,528 |
| 2,475,964 |
| 2,116,563 |
| 381,595 |
| 0.12 |
| 96.99 |
| - |
| - |
| -39.45 |
| -343,851 |
| 2024 |
|---|
| 871,720 |
| 62,940 |
| -421,468 |
| -421,468 |
| -30,431 |
| 33.98 |
| -48.35 |
| 25,528 |
| 2,475,964 |
| 2,116,563 |
| 381,595 |
| 0.12 |
| 96.99 |
| - |
| - |
| -39.45 |
| -343,851 |
Turnover (€)
2024
Turnover (€)
871,720 €67 % *
Sales per employee (€)
62,940 €96 % *
Profit before tax (€)
-421,468 €-1,400 % *
Net Profit (€)
-421,468 €-1,421 % *
Profit per employee (€)
-30,431 €-1,649 % *
Total profitability (%)
33.98 %-45.77 % *
Net profitability (%)
-48.35 %-890.03 % *
Equity (€)
25,528 €-94 % *
Amounts Payable And Liabilities (€)
2,475,964 €25 % *
Non-current Assets (€)
2,116,563 €7 % *
CurrentAssets (€)
381,595 €-16 % *
Working capital requirement
0.12 -81.82 % *
Debt-to-equity ratio
96.99 2,084.46 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
-39.45 %-305.04 % *
EBIT (€)
-343,851 €-443 % *
